Filing Details

Accession Number:
0000899243-19-006209
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-05 18:15:41
Reporting Period:
2019-03-01
Accepted Time:
2019-03-05 18:15:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1623613 Mylan N.v. MYL Pharmaceutical Preparations (2834) 981189497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657568 Paul Campbell Building 4, Trident Place, Mosquito Way
Hatfield, Hertfordshire X0 AL10 9UL
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-03-02 1,980 $0.00 24,540 No 4 M Direct
Ordinary Shares Disposition 2019-03-02 877 $27.45 23,663 No 4 F Direct
Ordinary Shares Acquisiton 2019-03-02 167 $0.00 437 No 4 M Indirect By Spouse
Ordinary Shares Disposition 2019-03-02 57 $27.45 380 No 4 F Indirect By Spouse
Ordinary Shares Acquisiton 2019-03-03 830 $0.00 24,493 No 4 M Direct
Ordinary Shares Disposition 2019-03-03 356 $27.45 24,137 No 4 F Direct
Ordinary Shares Acquisiton 2019-03-03 219 $0.00 599 No 4 M Indirect By Spouse
Ordinary Shares Disposition 2019-03-03 75 $27.45 524 No 4 F Indirect By Spouse
Ordinary Shares (Pursuant To Existing Trading Plan) Acquisiton 2019-03-04 11,533 $12.15 35,670 No 4 X Direct
Ordinary Shares (Pursuant To Existing Trading Plan) Disposition 2019-03-04 11,533 $27.50 24,137 No 4 S Direct
Ordinary Shares Disposition 2019-03-05 524 $0.00 0 No 5 G Indirect By Spouse
Ordinary Shares Acquisiton 2019-03-05 524 $0.00 24,661 No 5 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Indirect By Spouse
No 4 F Indirect By Spouse
No 4 M Direct
No 4 F Direct
No 4 M Indirect By Spouse
No 4 F Indirect By Spouse
No 4 X Direct
No 4 S Direct
No 5 G Indirect By Spouse
No 5 G Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option - Right to Buy Acquisiton 2019-03-01 7,398 $0.00 7,398 $27.45
Ordinary Shares Employee Stock Option - Right to Buy Acquisiton 2019-03-01 460 $0.00 460 $27.45
Ordinary Shares Restricted Stock Units Acquisiton 2019-03-01 12,387 $0.00 12,387 $0.00
Ordinary Shares Restricted Stock Units Acquisiton 2019-03-01 1,154 $0.00 1,154 $0.00
Ordinary Shares Restricted Stock Units Disposition 2019-03-02 1,980 $0.00 1,980 $0.00
Ordinary Shares Restricted Stock Units Disposition 2019-03-02 167 $0.00 167 $0.00
Ordinary Shares Restricted Stock Units Disposition 2019-03-03 830 $0.00 830 $0.00
Ordinary Shares Restricted Stock Units Disposition 2019-03-03 219 $0.00 219 $0.00
Ordinary Shares Employee Stock Option - Right to Buy Disposition 2019-03-04 11,533 $0.00 11,533 $12.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,398 2029-03-01 No 4 A Direct
460 2029-03-01 No 4 A Indirect
12,387 No 4 A Direct
1,154 No 4 A Indirect
3,960 No 4 M Direct
334 No 4 M Indirect
830 No 4 M Direct
220 No 4 M Indirect
0 No 4 X Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 318 Indirect By 401(k) Plan
Footnotes
  1. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2018.
  2. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 3, 2017.
  3. The exercise of stock options and sale of ordinary shares were executed pursuant to a 10b5-1 trading plan executed on March 5, 2018.
  4. Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 5, 2009.
  5. Represents the weighted average price of the reporting person's disposition of 11,533 ordinary shares in transactions ranging from $27.37 to $27.59. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
  6. This transaction involved a gift of securities by the reporting person's spouse to the reporting person on March 5, 2019.
  7. These options vest in three equal annual installments beginning on March 2, 2020 and expire on March 1, 2029.
  8. 154 of the options will vest on March 2, 2020, and 153 will vest on each of March 2, 2021 and March 2, 2022. The options expire on March 1, 2029.
  9. Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2020.
  10. Each RSU represents the right to receive one ordinary share of Mylan N.V. 385 of the RSUs will vest on March 2, 2020, 384 will vest on March 2, 2021, and 385 will vest on March 2, 2022.
  11. Each RSU represents the right to receive one ordinary share of Mylan N.V. One-third of the RSUs granted on March 2, 2018 vested on March 2, 2019 and the remainder of this award will vest equally on March 2, 2020 and March 2, 2021.
  12. Each RSU represents the right to receive one ordinary share of Mylan N.V. 831 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 830 vested on March 3, 2019, and 830 will vest on March 3, 2020.
  13. Each RSU represents the right to receive one ordinary share of Mylan N.V. 220 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 219 vested on March 3, 2019, and 220 will vest on March 3, 2020.
  14. The grant, of which these options were a part, vested in three equal annual installments beginning on March 5, 2010.